These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 1109784)
1. Activity of 6-methyl-8-substituted ergolines against the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma. Sweeney MJ; Poore GA; Kornfeld EC; Bach NJ; Owen NV; Clemens JA Cancer Res; 1975 Jan; 35(1):106-9. PubMed ID: 1109784 [TBL] [Abstract][Full Text] [Related]
2. Comparative effects of a series of prolactin inhibitors, 17beta-estradiol and 2alpha-methyldihydrotestosterone propionate, on growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas. Teller MN; Stock CC; Hellman L; Mountain IM; Bowie M; Rosenberg BJ; Boyar RM; Budinger JM Cancer Res; 1977 Nov; 37(11):3932-8. PubMed ID: 409489 [TBL] [Abstract][Full Text] [Related]
3. Predominant role of prolactin in stimulating the growth of 7, 12-dimethylbenz(a)anthracene-induced rat mammary tumor. Manni A; Trujillo JE; Pearson OH Cancer Res; 1977 Apr; 37(4):1216-9. PubMed ID: 191182 [TBL] [Abstract][Full Text] [Related]
4. Effects of 4-nitroestrone 3-methyl ether on dimethylbenz(a)anthracene-induced mammary tumors. Rozhin J; Ludwig EH; Corombos J; Odden D; Horwitz JP; Hughes R; Hughes DE; Wilson E; Brooks SC Cancer Res; 1983 Jun; 43(6):2611-7. PubMed ID: 6406049 [TBL] [Abstract][Full Text] [Related]
5. Effects of ergocornine and ergocryptine on growth of 7,12-dimethylbenzanthracene-induced mammary tumors in rats. Cassell EE; Meites J; Welsch CW Cancer Res; 1971 Jul; 31(7):1051-3. PubMed ID: 5560385 [No Abstract] [Full Text] [Related]
6. Is there any association between elevated serum prolactin level and mammary adenocarcinoma induced by 7,12-dimethylbenz(alpha)anthracene. Feuer G; Kellen JA; Kovacs K Res Commun Chem Pathol Pharmacol; 1975 Jul; 11(3):435-44. PubMed ID: 807960 [TBL] [Abstract][Full Text] [Related]
7. Correlation between serum prolactin levels and incidence of mammary tumors induced by 7,12-dimethylbenz(alpha)anthracene in the rat. Gala RR; Loginsky SJ J Natl Cancer Inst; 1973 Aug; 51(2):593-7. PubMed ID: 4765374 [No Abstract] [Full Text] [Related]
8. Relation of prolactin and estrogen to mammary tumorigenesis in the rat. Meites J J Natl Cancer Inst; 1972 Apr; 48(4):1217-24. PubMed ID: 5023679 [No Abstract] [Full Text] [Related]
9. Interaction of dietary fat and the thymus in the induction of mammary tumors by 7,12-dimethylbenz(a)anthracene. Wagner DA; Naylor PH; Kim U; Shea W; Ip C; Ip MM Cancer Res; 1982 Apr; 42(4):1266-73. PubMed ID: 6800650 [TBL] [Abstract][Full Text] [Related]
10. Factors influencing the anticarcinogenic efficacy of selenium in dimethylbenz[a]anthracene-induced mammary tumorigenesis in rats. Ip C Cancer Res; 1981 Jul; 41(7):2683-6. PubMed ID: 6788360 [TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of casein-producing and -nonproducing cell populations from 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas. Johnson ML; Levy J; Rosen JM Cancer Res; 1983 May; 43(5):2199-209. PubMed ID: 6187446 [TBL] [Abstract][Full Text] [Related]
12. Carcinogenicity of derivatives of 7,12-dimethylbenz(a)anthracene. Flesher JW; Sydnor KL Cancer Res; 1971 Dec; 31(12):1951-4. PubMed ID: 5120292 [No Abstract] [Full Text] [Related]
13. Role of prolactin in the promotion of dimethylbenz[a]anthracene-induced mammary tumors by dietary fat. Ip C; Yip P; Bernardis LL Cancer Res; 1980 Feb; 40(2):374-8. PubMed ID: 6766086 [TBL] [Abstract][Full Text] [Related]
14. Mammary neoplasia in Sprague-Dawley or Long-Evans rats after in vitro 7, 12-dimethylbenz(alpha) anthracene. Brown RD; Shellabarger CJ Cancer Res; 1974 Oct; 34(10):2594-5. PubMed ID: 4414561 [No Abstract] [Full Text] [Related]
15. Effects of multiple pituitary homografts or progesterone on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in rats. Welsch CW; Clemens JA; Meites J J Natl Cancer Inst; 1968 Aug; 41(2):465-71. PubMed ID: 5671287 [No Abstract] [Full Text] [Related]
16. Hormonal treatment of mammary tumors in rats induced by 3-methylcholanthrene (NSC-21970) and 7,12-dimethylbenz(alpha)anthracene (NSC-408823). Shimkin MB; Gropper L; Thatcher D; Gruenstein M Cancer Res; 1967 Nov; 27(11 Pt 2):1284-8. PubMed ID: 5630409 [No Abstract] [Full Text] [Related]
17. Influence of insulin administration on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in intact, oophorectomized, and hypophysectomized rats. Heuson JC; Legros N; Heimann R Cancer Res; 1972 Feb; 32(2):233-8. PubMed ID: 5058184 [No Abstract] [Full Text] [Related]
18. Criteria for evaluating hormones in the 7,12-dimethylbenz[a]-anthracene-induced mammary tumor-rat experimental chemotherapy system. Teller MN; Kaufman RJ; Stock CC; Bowie M Cancer Res; 1968 Feb; 28(2):368-71. PubMed ID: 5694312 [No Abstract] [Full Text] [Related]
19. Studies of prostaglandins in rat mammary tumors induced by 7,12-dimethylbenz(a)anthracene. Tan WC; Privett OS; Goldyne ME Cancer Res; 1974 Dec; 34(12):3229-31. PubMed ID: 4429952 [No Abstract] [Full Text] [Related]
20. Prolactin stimulation of estrogen receptor in vitro in 7,12 dimethylbenz(A)anthracene-induced mammary tumor. Sasaki GH; Leung BS Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):409-12. PubMed ID: 4369071 [No Abstract] [Full Text] [Related] [Next] [New Search]